9TYG image
Deposition Date 2026-01-19
Release Date 2026-02-11
Last Version Date 2026-02-18
Entry Detail
PDB ID:
9TYG
Title:
Structure of the MAP2K MEK1 in an inactive conformation in complex with its substrate MAPK ERK2
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Dual specificity mitogen-activated protein kinase kinase 1,Uncharacterized protein,Dual specificity mitogen-activated protein kinase kinase 1
Gene (Uniprot):TGME49_230180, MAP2K1
Mutagens:residue 3-11 replaced with 15 residues GRA24 KIM,Ser218Asp,Ser222Asp
Chain IDs:A
Chain Length:405
Number of Molecules:1
Biological Source:Homo sapiens, Toxoplasma gondii ME49
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 1
Gene (Uniprot):MAPK1
Mutagens:Thr185Val
Chain IDs:B
Chain Length:363
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Molecular basis of mitogen-activated protein kinase ERK2 activation by its upstream kinase MEK1.
Biorxiv ? ? ? (2026)
PMID: 41648251 DOI: 10.64898/2026.01.19.700303

Abstact

The RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) pathway relays extracellular signals into a cellular response and its dysregulation leads to many pathologies, particularly cancer. Here, we determined cryo-EM structures of the MAP2K MEK1 activating its substrate MAPK ERK2, the final event in the cascade. We define the molecular details of specificity and phosphoryl transfer to the tyrosine of the ERK2 activation loop and examine the mechanism of substrate recognition using solution techniques and molecular dynamics. Binding of the substrate MAPK leads to release of the MAP2K catalytic machinery, explaining the mechanism of many disease-causing mutations, and ERK2 release is not required for nucleotide exchange, suggesting a processive mechanism. Our data advance the understanding of MAPK signalling and provide a starting point for drug development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback